12/07/2005 (Agence Europe) - The Commission has approved aid of EUR 45.2 million in favour of a research and development project for the pharmaceuticals company, Portela & S.A. (known as BIAL), in the Portuguese region of Norte. The region is eligible for regional aid (Article 87§3.a), as well as under Objective 1, and the project meets the requirements of Community rules, the Commission noted last week. BIAL, which is the seventh pharmaceuticals company on the Portuguese market, hopes to...